Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism

scientific article published on 16 October 2018

Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CNS.13074
P932PMC publication ID6488924
P698PubMed publication ID30328295

P50authorPablo BlinderQ38328938
Feng HanQ87811285
Ying-Mei LuQ92346075
P2093author name stringHuan Wang
Gang Wu
Quan Jiang
Sen Long
Cheng-Kun Wang
Dong-Mei Gong
Ling-Juan Hong
Yi-Xuan Yin
P2860cites workFrom molecules to neural morphology: understanding neuroinflammation in autism spectrum conditionQ26770325
Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateQ26782938
Modeling psychiatric disorders for developing effective treatmentsQ26784269
Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory diseaseQ26822941
Inflammasomes: mechanism of action, role in disease, and therapeuticsQ27001186
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrierQ27303034
A computational perspective on autismQ27320751
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor proteinQ28264162
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injuryQ28286412
Infant siblings and the investigation of autism risk factorsQ28388355
AMPAKINE enhancement of social interaction in the BTBR mouse model of autismQ28388762
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombiQ28513807
Autism-like behavioral phenotypes in BTBR T+tf/J miceQ29615512
Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010Q29615713
Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brainQ30452927
National autism prevalence trends from United States special education dataQ30983930
Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.Q33685348
Adhesion molecule expression and regulation on cells of the central nervous systemQ33701566
Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivoQ33722929
Plasma cytokine profiles in subjects with high-functioning autism spectrum disordersQ33925249
In vivo two-photon fluorescence microscopy reveals disturbed cerebral capillary blood flow and increased susceptibility to ischemic insults in diabetic miceQ34066952
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposuresQ34238394
Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorderQ34282952
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeQ34348399
Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunityQ34605988
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.Q35350543
Adhesion molecules and atherosclerosisQ35581561
P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathyQ35638779
Chemokines: multiple levels of leukocyte migration control.Q35753105
Neuro-inflammation, blood-brain barrier, seizures and autismQ35800334
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsQ35887816
MET is required for the recruitment of anti-tumoural neutrophilsQ36125652
Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brainQ36135928
Large brains in autism: the challenge of pervasive abnormalityQ36252809
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.Q36731062
Getting leukocytes to the site of inflammationQ36772662
Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunctionQ36861439
Autism spectrum disorder: advances in evidence-based practiceQ37702247
Microglia in neurodegenerative diseaseQ37710380
Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adultsQ37984014
Potential cytokine biomarkers in autism spectrum disordersQ38268751
The role of inflammation and microglial activation in the pathophysiology of psychiatric disordersQ38485016
Immune mediators in the brain and peripheral tissues in autism spectrum disorderQ38550206
Immune Alterations in CD8(+) T Cells Are Associated with Neuronal C-C and C-X-C Chemokine Receptor Regulation Through Adenosine A2A Receptor Signaling in a BTBR T(+) Itpr3(tf)/J Autistic Mouse Model.Q38728524
Cathepsin B and L inhibitors: a patent review (2010 - present).Q39044784
ICAM-1 clustering on endothelial cells recruits VCAM-1Q39668039
Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classificationQ39883042
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.Q41270272
Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder.Q41501738
Effects of cathepsins B and L inhibition on postischemic protein alterations in the brainQ41845961
NLRs and the dangers of pollution and agingQ42554239
Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammationQ42736872
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecidQ46398714
Altered plasma levels of chemokines in autism and their association with social behaviorsQ47406645
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum DisordersQ47556317
Melatonin reverses the decreases in hippocampal protein serine/threonine kinases observed in an animal model of autismQ47763262
Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder.Q50210143
Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth.Q50313597
Brain cytokines and neuropsychiatric disorders.Q51935715
P4510describes a project that usesImageJQ1659584
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectautismQ38404
P304page(s)476-485
P577publication date2018-10-16
P1433published inCNS Neuroscience & TherapeuticsQ5013184
P1476titleCathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism
P478volume25

Reverse relations

Q98465071The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorderscites workP2860

Search more.